Axiron FDA Approval History
FDA Approved: Yes (Discontinued) (First approved November 23, 2010)
Brand name: Axiron
Generic name: testosterone
Dosage form: Topical Solution
Company: Eli Lilly and Company
Treatment for: Hypogonadism, Male
Marketing Status: Discontinued
Axiron (testosterone) is an androgen indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
The FDA posted a notice regarding the discontinuation of manufacture of Axiron in September 2017. The product was not discontinued or withdrawn for safety or efficacy reasons.
Development timeline for Axiron
| Date | Article |
|---|---|
| Nov 24, 2010 | Approval Lilly and Acrux Receive FDA Approval for Axiron (Testosterone) Topical Solution CIII |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
